Yamamori, Hidenaga

The genetic architecture of the human cerebral cortex

Grasby, K. L., Jahanshad, N., Painter, J. N., Colodro-Conde, L., Bralten, J., Hibar, D. P., Lind, P. A., Pizzagalli, F., Ching, C. R. K., McMahon, M. A. B., et al. (2020) · Science

Genetic Associations and EpidemiologyCognitive Abilities and Testing

Cited by 876

Widespread white matter microstructural differences in schizophrenia across 4322 individuals: results from the ENIGMA schizophrenia DTI working group

Kelly, S., Jahanshad, N., Zalesky, A., Kochunov, P., Agartz, I., Alloza, C., Andreassen, O. A., Arango, C., Banaj, N., Bouix, S., et al. (2018) · Molecular Psychiatry

Schizophrenia research and treatmentAdvanced Neuroimaging Techniques and Applications

Cited by 701

Comparative Analyses of Copy-Number Variation in Autism Spectrum Disorder and Schizophrenia Reveal Etiological Overlap and Biological Insights

Kushima, I., Aleksic, B., Nakatochi, M., Shimamura, T., Okada, T., Uno, Y., Morikawa, M., Ishizuka, K., Shiino, T., Kimura, H., et al. (2018) · Cell Reports

Genomic variations and chromosomal abnormalitiesAutism Spectrum Disorder Research

Cited by 251

Failure of Neuronal Maturation in Alzheimer Disease Dentate Gyrus

Li, B., Yamamori, H., Tatebayashi, Y., Shafit-Zagardo, B., Tanimukai, H., Chen, S., Iqbal, K., & Grundke-Iqbal, I. (2008) · Journal of Neuropathology & Experimental Neurology

Neurogenesis and neuroplasticity mechanismsAlzheimer's disease research and treatments

Cited by 234

Plasma levels of mature brain-derived neurotrophic factor (BDNF) and matrix metalloproteinase-9 (MMP-9) in treatment-resistant schizophrenia treated with clozapine.

Yamamori, H., Hashimoto, R., Ishima, T., Kishi, F., Yasuda, Y., Ohi, K., Fujimoto, M., Umeda-Yano, S., Ito, A., Hashimoto, K., et al. (2013) · Neuroscience Letters

Schizophrenia research and treatmentTryptophan and brain disorders

Cited by 101

Dose response of the 16p11.2 distal copy number variant on intracranial volume and basal ganglia

Sønderby, I. E., Gústafsson, Ó., Doan, N. T., Hibar, D. P., Martin-Brevet, S., Abdellaoui, A., Ames, D., Amunts, K., Andersson, M., Armstrong, N. J., et al. (2020) · Molecular Psychiatry

Genomic variations and chromosomal abnormalitiesGenetics and Neurodevelopmental Disorders

Cited by 66

Assessment of a Multi-Assay Biological Diagnostic Test for Mood Disorders in a Japanese Population

Yamamori, H., Ishima, T., Yasuda, Y., Fujimoto, M., Kudo, N., Ohi, K., Hashimoto, K., Takeda, M., & Hashimoto, R. (2016) · Neuroscience Letters

Bipolar Disorder and TreatmentTreatment of Major Depression

Cited by 19

RacGAP α2-Chimaerin Function in Development Adjusts Cognitive Ability in Adulthood

Iwata, R., Ohi, K., Kobayashi, Y., Masuda, A., Iwama, M., Yasuda, Y., Yamamori, H., Tanaka, M., Hashimoto, R., Itohara, S., et al. (2014) · Cell Reports

Memory and Neural MechanismsNeurogenesis and neuroplasticity mechanisms

Cited by 16

Retraction Note: A significant causal association between C-reactive protein levels and schizophrenia

Inoshita, M., Numata, S., Tajima, A., Kinoshita, M., Umehara, H., Nakataki, M., Ikeda, M., Maruyama, S., Yamamori, H., Kanazawa, T., et al. (2018) · Scientific Reports

Schizophrenia research and treatmentTryptophan and brain disorders

Cited by 10